SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rosetta Genomics (ROSG) - microRNA
An SI Board Since July 2007
Posts SubjectMarks Bans Symbol
58 8 0 ROSG
Emcee:  Microcap Analyst Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8I think ROSG IPO’d too early amid the hype surrounding ALNY and the RNAi Nobel pDewDiligence_on_SI-10/30/2007
7Collins Stewart sees triple opportunity at Rosetta Rosetta Genomics is currentlybob zagorin-10/30/2007
6ROSG news; <i>Rosetta Genomics Completes Prevalidation Phase for First DiSteve Lokness-10/30/2007
5October 2, 2007, 2:22 pm The Next, Next Big Thing: Really Tiny RNA Posted by Jacbob zagorin-10/19/2007
4Alnylam Shares Rise on Cantor Upgrade Tuesday September 11, 10:05 am ET Alnylambob zagorin-9/11/2007
3Rosetta Genomics Reports Second Quarter 2007 Financial Results Thursday August 2bob zagorin-8/2/2007
2Rosetta Genomics Shares Rise on Note Tuesday July 24, 12:25 pm ET Rosetta Genomibob zagorin-7/26/2007
1ROSG ($7.33, $87M mkt cap). The Next Generation RNAi Company. * MicroRNAs are tMicrocap Analyst-7/13/2007
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News